Marginal Zone Lymphoma
Showing NaN - NaN of 20
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (tafasitamab, rituximab, lenalidomide)
Recruiting
- Follicular Lymphoma
- Marginal Zone Lymphoma
- tafasitamab
- +3 more
-
Concord, California
- +255 more
Dec 1, 2022
DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)
Terminated
- Diffuse Large B-Cell Lymphoma
- +4 more
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +167 more
Jul 20, 2022
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16
Recruiting
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
- +5 more
-
Duarte, California
- +12 more
Jun 16, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib (ME-401))
Recruiting
- Follicular Lymphoma (FL)
- +2 more
- Zandelisib (ME-401)
-
Tucson, Arizona
- +115 more
Mar 8, 2022
Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,
Active, not recruiting
- Follicular Lymphoma
- +3 more
- Vitamin D
- +2 more
-
Miami, Florida
- +6 more
Mar 6, 2022
Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)
Recruiting
- Cancer, Metastatic
- +42 more
- Clinical Trial Matching
-
New York, New YorkMassive Bio, Inc
May 21, 2021
Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York
Completed
- Diffuse Large B Cell Lymphoma
- +4 more
- Tazemetostat
- +3 more
-
Tucson, Arizona
- +2 more
Mar 23, 2021
Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)
Completed
- Marginal Zone Lymphoma
- B-cell Lymphoma
-
Tucson, Arizona
- +24 more
Oct 8, 2019
Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)
Completed
- Follicular Lymphoma
- +3 more
-
Fullerton, California
- +40 more
Jun 14, 2019
Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)
Completed
- Indolent Non-Hodgkin's Lymphoma
- +3 more
-
Palo Alto, California
- +1 more
Oct 19, 2018